Antibiotic resistance rates in Cutibacterium acnes isolated from patients with acne vulgaris: a systematic review and meta-analysis
Authors:
Top Cited Papers
Open Access
- 4 June 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1565111
Abstract
Background: Cutibacterium acnes (C. acnes) is closely related to the pathogenesis of acne, and studies related to the antibiotic resistance rates of C. acnes have been reported worldwide; however, relevant systematic reviews and meta-analyses are still lacking. The aim of this study was to systematically evaluate the resistance in C. acnes to relevant antibiotics, that this information may be used to provide a rational basis for the antibiotic treatment of acne.Methods: Relevant studies in PubMed, the Cochrane Library, EMBASE, Web of Science, China National Knowledge Infrastructure (CNKI) and Wanfang Data were systematically searched from January 1, 2005, to April 1, 2025, and the resistance rates of C. acnes isolates to quinolones, macrolides, tetracyclines, and other relevant antibiotics were collected. The combined resistance rate was calculated via the R language program package 4.3.2, with subgroup analyses based on different years, continents, countries, provinces in China and different drug susceptibility testing methods.Results: A total of 8,846 studies were systematically retrieved and 23 studies were included, corresponding to 2,046 isolates of C. acnes, which have shown antibiotic resistance rates ranging from high to low: 48.17% (95% CI: 41.16–55.24%) for roxithromycin, 45.64% (95% CI: 20.49–73.22%) for clarithromycin, 43.33% (95% CI: 27.81–60.29%) for azithromycin, 29.20% (95% CI: 22.14–37.43%) for erythromycin, 22.38% (95% CI: 14.69–32.56%) for clindamycin, 5.93% (95% CI: 2.91–11.69%) for levofloxacin, 2.44% (95% CI: 0.99–5.89%) for doxycycline, 1.47% (95% CI: 0.00–85.72%) for trimethoprim-sulfamethoxazole (TMP–SMX), 1.31% (95% CI: 0.45–3.70%) for tetracycline, 0.28% (95% CI: 0.04–1.94%) for chloramphenicol, 0.22% (95% CI: 0.03–1.89%) for minocycline. Subgroup analysis revealed that, compared with those in other regions, the resistance rates to macrolides and clindamycin were higher in China. In addition, the levofloxacin, erythromycin, and clindamycin resistance rates were progressively increasing over time.Conclusion: In certain regions, the relatively high antibiotic resistance rates (e.g., 77% (95% CI: 62–87%) for clarithromycin in China) in C. acnes isolates may be attributed to the overuse of antibiotics in acne treatment. The resistance rates in C. acnes to tetracyclines, such as 2.44% (95% CI: 0.99–5.89%) for doxycycline, remain relatively low, which allows tetracyclines to continue serving as first-line antibiotics for acne treatment. In addition, the resistance rates to levofloxacin, erythromycin, and clindamycin markedly increased over time (p < 0.05). This emphasizes the significance of rational use of the antibiotics in acne treatment.Keywords
This publication has 85 references indexed in Scilit:
- Liver abscess caused by Cutibacterium namnetense after transarterial chemoembolization for hepatocellular carcinomaClinical Journal of Gastroenterology, 2020
- The Skin Microbiome: A New Actor in Inflammatory AcneAmerican Journal of Clinical Dermatology, 2020
- Propionibacterium/Cutibacterium species–related positive samples, identification, clinical and resistance features: a 10-year survey in a French hospitalEuropean Journal of Clinical Microbiology & Infectious Diseases, 2020
- From pathogenesis of acne vulgaris to anti-acne agentsArchives of Dermatological Research, 2019
- Acne, the Skin Microbiome, and Antibiotic TreatmentAmerican Journal of Clinical Dermatology, 2019
- Molecular dynamics simulations suggest why the A2058G mutation in 23S RNA results in bacterial resistance against clindamycinJournal of Molecular Modeling, 2018
- Antibiotic Resistance in Acne TreatmentJAMA Dermatology, 2017
- Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, ChinaFrontiers of Medicine, 2016
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986